11 Organisations from 6 EU Countries

The i-PROGNOSIS consortium includes 11 partners from 6 countries, all members of the European Union, namely, Greece (3), Belgium (1), Germany (2), Portugal (2), Sweden (1) and United Kingdom (1). All partners have excellent experience and capabilities related to the i-PROGNOSIS objectives and tasks in technological, health and healthy ageing policy domains.

 

GREECE
	Aristotle University of Thessaloniki Signal Processing and Biomedical Technology Unit Multimedia Understanding Group Dept. of Electrical & Computer Engineering Medical Physics Laboratory Dept. of Neurology Medical School
	Center for Research and Technology Hellas Information Technologies Institute
	Microsoft Innovation Center Greece
	COSMOTE Mobile Telecommunications S.A.
BELGIUM
	Age Platform Europe
GERMANY
	Technische Universitat Dresden Dept. of Neurology
	Fraunhofer Institute for Intelligent Analysis and Information Systems
PORTUGAL
	Faculdade de Motricidade Humana Universidade de Lisboa
	PLUX – Wireless Biosignals S.A.
SWEDEN
	Karolinska Institutet Dept. of Neurobiology, Care Sciences & Society
UNITED KINGDOM
	King’s College London, King’s College Hospital Dept. of Basic and Clinical Neuroscience

 

OUR STRENGTHS

Medical expertise

Medical partners of i-PROGNOSIS (KCL, TUD, AUTH, KI) are experts in Parkinson’s Disease and have experience in the roll out of health information technology (IT) programmes (KCL, TUD, AUTH, KI).

Technical expertise

Technical and engineering partners (AUTH, CERTH, COSMOTE, PLUX, FHM, FRAUNHOFER, MICROSOFT) have the necessary technical expertise so as to develop the individual modules of the i-PROGNOSIS platform and to integrate them into a robust system that can be deployed for early detection of Parkinson’s, as well as for the human intervention studies.

Policies expertise

i-PROGNOSIS partner AGE has a deep understanding of health/aging policy issues, necessary for highlighting the potential benefits and impacts of i-PROGNOSIS.